Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Neoplasms, Prostate
Interventions
DRUG

dutasteride

0.5mg dutasteride (Investigation Product)

DRUG

placebo

making placebo

DRUG

bicalutamide

50 mg Casodex or generic equivalent

Trial Locations (62)

10016

GSK Investigational Site, New York

11030

GSK Investigational Site, Manhasset

11530

GSK Investigational Site, Garden City

12208

GSK Investigational Site, Albany

13210

GSK Investigational Site, Syracuse

17604

GSK Investigational Site, Lancaster

19004

GSK Investigational Site, Bala-Cynwyd

19107

GSK Investigational Site, Philadelphia

20307

GSK Investigational Site, Washington D.C.

21401

GSK Investigational Site, Annapolis

23185

GSK Investigational Site, Williamsburg

23235

GSK Investigational Site, Richmond

23454

GSK Investigational Site, Virginia Beach

23502

GSK Investigational Site, Norfork

28025

GSK Investigational Site, Concord

29572

GSK Investigational Site, Myrtle Beach

32114

GSK Investigational Site, Daytona Beach

32803

GSK Investigational Site, Orlando

33180

GSK Investigational Site, Aventura

35209

GSK Investigational Site, Homewood

35801

GSK Investigational Site, Huntsville

38119

GSK Investigational Site, Memphis

43214

GSK Investigational Site, Columbus

46825

GSK Investigational Site, Fort Wayne

47130

GSK Investigational Site, Jeffersonville

47713

GSK Investigational Site, Evansville

53226

GSK Investigational Site, Milwaukee

55318

GSK Investigational Site, Chaska

55455

GSK Investigational Site, Minneapolis

61401

GSK Investigational Site, Galesburg

63136

GSK Investigational Site, St Louis

66211

GSK Investigational Site, Overland Park

68114

GSK Investigational Site, Omaha

70112

GSK Investigational Site, New Orleans

71106

GSK Investigational Site, Shreveport

72205

GSK Investigational Site, Little Rock

77074

GSK Investigational Site, Houston

78229

GSK Investigational Site, San Antonio

80211

GSK Investigational Site, Denver

89148

GSK Investigational Site, Las Vegas

92101

GSK Investigational Site, San Diego

92404

GSK Investigational Site, San Bernardino

92801

GSK Investigational Site, Anaheim

93720

GSK Investigational Site, Fresno

98166

GSK Investigational Site, Seattle

02472

GSK Investigational Site, Watertown

98195-6015

GSK Investigational Site, Seattle

T2V 1P9

GSK Investigational Site, Calgary

V3V 1N1

GSK Investigational Site, Surrey

V8T 5G1

GSK Investigational Site, Victoria

L4M 7G1

GSK Investigational Site, Barrie

L7S 1V2

GSK Investigational Site, Burlington

P3E 4T3

GSK Investigational Site, Greater Sudbury

P1B 7K8

GSK Investigational Site, North Bay

L6H 3P1

GSK Investigational Site, Oakville

M1S 4V5

GSK Investigational Site, Scarborough Village

M2K 2W1

GSK Investigational Site, Toronto

M4C 5T2

GSK Investigational Site, Toronto

J4V 2H3

GSK Investigational Site, Greenfield Park

H7G 2E6

GSK Investigational Site, Laval

H9R 4S3

GSK Investigational Site, Pointe-Claire

G1R 2J6

GSK Investigational Site, Québec

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY